Mutations and addiction to EGFR: the Achilles ‘heal’ of lung cancers?
- 1 October 2004
- journal article
- review article
- Published by Elsevier in Trends in Molecular Medicine
- Vol. 10 (10) , 481-486
- https://doi.org/10.1016/j.molmed.2004.08.008
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib TherapyScience, 2004
- Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to GefitinibNew England Journal of Medicine, 2004
- The discovery of receptor tyrosine kinases: targets for cancer therapyNature Reviews Cancer, 2004
- Why a New Cancer Drug Works Well, In Some PatientsScience, 2004
- Status of Epidermal Growth Factor Receptor Antagonists in the Biology and Treatment of CancerJournal of Clinical Oncology, 2003
- Antibody-mediated EGF receptor blockade as an anticancer therapy: from the laboratory to the clinicCancer Immunology, Immunotherapy, 2003
- Addiction to Oncogenes--the Achilles Heal of CancerScience, 2002
- The Conformational Plasticity of Protein KinasesPublished by Elsevier ,2002
- The protein tyrosine kinase family of the human genomeOncogene, 2000
- Comparative Genomics of the EukaryotesScience, 2000